Medite Cancer Diagnostics Stock Today
| MDIT Stock | USD 0.0001 0.00 0.00% |
PerformanceWeakest
| Odds Of DistressRisky
|
Medite Cancer is selling for under 1.0E-4 as of the 26th of December 2025; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. Medite Cancer has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 27th of September 2025 and ending today, the 26th of December 2025. Click here to learn more.
Medite Cancer Diagnostics, Inc. operates as a medical technology company. Medite Cancer Diagnostics, Inc. is based in Orlando, Florida. Medite Cancer operates under Medical Instruments Supplies classification in the United States and is traded on OTC Exchange. The company has 86.72 M outstanding shares. More on Medite Cancer Diagnostics
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medite Pink Sheet Highlights
| Business Concentration | Health Care, Health Care Equipment & Supplies, Medical Instruments & Supplies, Healthcare (View all Sectors) |
Medite Cancer Diagnostics [MDIT] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 520.34 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medite Cancer's market, we take the total number of its shares issued and multiply it by Medite Cancer's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medite Cancer Diagnostics conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 86.72 M outstanding shares.
Medite Cancer Diagnostics currently holds about 90 K in cash with (3.57 M) of positive cash flow from operations.
Check Medite Cancer Probability Of Bankruptcy
Medite Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medite Cancer without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Volatility Analysis Now
Volatility AnalysisGet historical volatility and risk analysis based on latest market data |
| All Next | Launch Module |
Additional Tools for Medite Pink Sheet Analysis
When running Medite Cancer's price analysis, check to measure Medite Cancer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medite Cancer is operating at the current time. Most of Medite Cancer's value examination focuses on studying past and present price action to predict the probability of Medite Cancer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medite Cancer's price. Additionally, you may evaluate how the addition of Medite Cancer to your portfolios can decrease your overall portfolio volatility.